trial

STimulation to Improve Auditory haLLucinations

NCTId NCT02360228
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 25 (actual)
Sponsored by University of North Carolina, Chapel Hill
Primary completion 2017-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
25 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2015-05
Primary completion
2017-02
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
tACS (alpha)TDCS

Sponsors

University of North Carolina, Chapel HillLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Flavio Frohlich, PhDPrincipal Investigator

Sites

1 total
Chapel Hill, United States

Facts & assertions

4 sourced
Enrollment
25
Phase
NA
Primary Completion Date
2017-02
Status
COMPLETED
relationships
The graph out of here
drug
tACS (alpha)
drug
TDCS
drug
lead_sponsor
University of North Carolina, Chapel Hill
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Hallucinations
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Flavio Frohlich, PhD
person